Strong association between two polymorphisms on 15q25.1 and lung cancer risk: A meta-analysis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Gu, Mingliang ^a   Dong, Xiaoqun ^b   Zhang, Xuezhi ^c   Wang, Xumin ^a   Qi, Yue ^d   Yu, Jun ^a   Niu, Wenquan ^e  

^a Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c China Petrochemical Corporation   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGPHD1 GENE; ALLELE; ARTICLE; ASIAN; CANCER GROWTH; CANCER RISK; CAUCASIAN; CHRNA3 GENE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 15Q; ETHNIC DIFFERENCE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; HETEROZYGOTE; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; CHROMOSOME 15; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MEDLINE; META ANALYSIS; RISK;

HYDROXYLYSINE KINASE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR SUBUNIT ALPHA3; PHOSPHOTRANSFERASE;

ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOMES, HUMAN, PAIR 15; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; ODDS RATIO; PHOSPHOTRANSFERASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBMED; RECEPTORS, NICOTINIC;

EID: 84862019276     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037970     Document Type: Article

References (34)

1. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ, (2002) Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2: 37.
2. Herbst RS, Heymach JV, Lippman SM, (2008) Lung cancer. N Engl J Med 359: 1367-1380.
3. Xu H, Spitz MR, Amos CI, Shete S, (2005) Complex segregation analysis reveals a multigene model for lung cancer. Hum Genet 116: 121-127.
4. Heller G, Zielinski CC, Zochbauer-Muller S, (2010) Lung cancer: from single-gene methylation to methylome profiling. Cancer Metastasis Rev 29: 95-107.
5. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40: 616-622.
6. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642.
7. Broderick P, Wang Y, Vijayakrishnan J, Matakidou A, Spitz MR, et al. (2009) Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res 69: 6633-6641.
8. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633-637.
9. McClellan J, King MC, (2010) Genetic heterogeneity in human disease. Cell 141: 210-217.
10. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151: 264-269, W264.
11. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, et al. (2005) Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162: 201-211.
12. Cohn LD, Becker BJ, (2003) How meta-analysis increases statistical power. Psychol Methods 8: 243-253.
13. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
15. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
16. Amos CI, Gorlov IP, Dong Q, Wu X, Zhang H, et al. (2010) Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. J Natl Cancer Inst 102: 1199-1205.
17. Broderick P, Wang Y, Vijayakrishnan J, Matakidou A, Spitz MR, et al. (2009) Deciphering the Impact of Common Genetic Variation on Lung Cancer Risk: A Genome-Wide Association Study. Cancer Research 69: 6633-6641.
18. Girard N, Lou E, Azzoli CG, Reddy R, Robson M, et al. (2010) Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report. Clin Cancer Res 16: 755-763.
19. Kohno T, Kunitoh H, Mimaki S, Shiraishi K, Kuchiba A, et al. (2011) Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinoma. J Thorac Oncol 6: 813-817.
20. Liu P, Vikis HG, Wang D, Lu Y, Wang Y, et al. (2008) Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst 100: 1326-1330.
21. Sakoda LC, Loomis MM, Doherty JA, Neuhouser ML, Barnett MJ, et al. (2011) Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers. Cancer Causes Control 22: 449-461.
22. Schwartz AG, Cote ML, Wenzlaff AS, Land S, Amos CI, (2009) Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer. J Thorac Oncol 4: 1195-1201.
23. Shiraishi K, Kohno T, Kunitoh H, Watanabe S, Goto K, et al. (2009) Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis 30: 65-70.
24. Spitz MR, Amos CI, Dong Q, Lin J, Wu X, (2008) The CHRNA5-A3 Region on Chromosome 15q24-25.1 Is a Risk Factor Both for Nicotine Dependence and for Lung Cancer. JNCI Journal of the National Cancer Institute 100: 1552-1556.
25. Zienolddiny S, Skaug V, Landvik NE, Ryberg D, Phillips DH, et al. (2009) The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis 30: 1368-1371.
26. Wu C, Hu Z, Yu D, Huang L, Jin G, et al. (2009) Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res 69: 5065-5072.
27. Hemminki K, Lorenzo Bermejo J, Forsti A, (2006) The balance between heritable and environmental aetiology of human disease. Nat Rev Genet 7: 958-965.
28. Yu K, Zhang J, Dou C, Gu S, Xie Y, et al. (2010) Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis. Eur J Hum Genet 18: 370-378.
29. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642.
30. Salanti G, Sanderson S, Higgins JP, (2005) Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med 7: 13-20.
31. Ruano-Ravina A, Perez-Rios M, Barros-Dios JM, (2008) Population-based versus hospital-based controls: are they comparable? Gac Sanit 22: 609-613.
32. Biesalski HK, Bueno de Mesquita B, Chesson A, Chytil F, Grimble R, et al. (1998) European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel. CA Cancer J Clin 48: 167-176; discussion 164-166.
33. Tseng RC, Hsieh FJ, Shih CM, Hsu HS, Chen CY, et al. (2009) Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study. Cancer 115: 2939-2948.
34. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I, (2006) The case of the misleading funnel plot. BMJ 333: 597-600.